Search

Coloplast A-S (Class B)

Fermé

573.4

Résumé

Variation du prix de l'action

24h

Actuel

Min

568

Max

576.6

Chiffres clés

By Trading Economics

Revenu

70M

875M

Ventes

2M

7B

P/E

Moyenne du Secteur

35.807

90.831

BPA

3.88

Rendement du dividende

4.01

Marge bénéficiaire

12.572

Employés

16,744

EBITDA

2B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.01%

2.20%

Prochains Résultats

6 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

7.5B

130B

Ouverture précédente

573.4

Clôture précédente

573.4

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 janv. 2026, 18:44 UTC

Principaux Mouvements du Marché

Agenus Falls After $141 Million Zydus Deal Closes

15 janv. 2026, 17:51 UTC

Principaux Mouvements du Marché

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 janv. 2026, 17:25 UTC

Principaux Mouvements du Marché

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 janv. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 janv. 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 janv. 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15 janv. 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 janv. 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15 janv. 2026, 22:56 UTC

Market Talk
Résultats

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 janv. 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 janv. 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 janv. 2026, 21:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Energy & Utilities Roundup: Market Talk

15 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 janv. 2026, 21:27 UTC

Résultats

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 janv. 2026, 21:15 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Commodities Roundup: Market Talk

15 janv. 2026, 21:11 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

15 janv. 2026, 21:11 UTC

Market Talk
Acquisitions, Fusions, Rachats

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 janv. 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 janv. 2026, 20:04 UTC

Résultats

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 janv. 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 janv. 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15 janv. 2026, 18:29 UTC

Principaux Mouvements du Marché

Agenus Falls After $141M Zydus Deal Closes

15 janv. 2026, 18:20 UTC

Résultats

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 janv. 2026, 17:56 UTC

Market Talk
Résultats

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 janv. 2026, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Auto & Transport Roundup: Market Talk

15 janv. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 janv. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 janv. 2026, 17:02 UTC

Acquisitions, Fusions, Rachats

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat